REGENHU

Company Snapshot

Founded: 2007

Entity Type: Private

Region: Switzerland

Headquarter: Villaz-St-Pierre, Switzerland

Key Geographics: Switzerland, U.S.

Corporate Address: ZI du Vivier 22, 1690 Villaz-St-Pierre, Switzerland Tel. +41-26-653-7220 www.regenhu.com

Company Overview

regenHU is a Switzerland-based med-tech company offering 3D-based bioprinting technology products and software. The company caters to a variety of applications, including drug discovery, tablet printing, human skin printing, personalized medicine, and more. The company has offices across various locations in Switzerland and the U.S.

REGENHU In Reports

Global Markets for 3D Printing

BCC Research Market Analyst says global market for 3D printing is expected to grow from $18.0 billion in 2024 and is projected to reach $29.4 billion by the end of 2029, at a CAGR of 10.2%.

3D Printing Medical Devices: Global Markets

BCC Research Market Analyst says global market for 3D printing medical devices reached $2.1 billion in 2023 & estimated to grow from $2.2 billion in 2024 to $4.5 billion by the end of 2029.

Advanced Materials for 3D Printing: Technologies and Global Markets

Global advanced materials for 3D printing market should reach $2.5 billion by 2022 and more than $6.5 billion by 2027, with a CAGR of 20.7% during the forecast period of 2022-27.

View All Reports

Company's Business Segments

Products : The company generates revenue from several products such as Shaper, R-Gen 100, R-Gen 200.
Services : The company also provide services for Human Skin Printing, Tablet Printing, Drug Discovery, Publications and Application Notes.

Applications/End User Industries

Health Technology
Life Sciences

Health Care
Skin Researchers